Masimo, for its part, has declared racial bias a non-issue in its own flagship SET pulse oximeter: Study results (PDF) published this month found no clinically significant difference in the device ...

The new results build on previous analyses of the same data set, comprising 39 Black patients and 36 white patients who repeatedly used Masimo’s SET pulse oximeters—alongside arterial blood ...

FDA guidance for approving pulse oximeters says clinical trials should ... the New England Journal of Medicine article, the CEO of Masimo Corp. suggested several hypotheses might account for ...

“It’s a valid concern to make sure pulse oximeters or other technologies work on all people,” said Joe Kiani, the founder, chairman, and CEO of Masimo, adding that he can’t speak for the ...

Apple infringed on one of medical technology company Masimo's pulse oximeter patents when it launched Apple Watch models that use light sensors to measure the amount of oxygen in the blood ...

Today’s report is the latest episode in a long-running battle between the two companies over whether or not the Apple Watch’s pulse oximeter uses Masimo’s patented tech … Way back in 2013 ...

Masimo, a company that says it has the most accurate pulse oximeters on the market, would happily comply with any FDA guidance, Daniel Cantillon, Masimo's chief medical officer, said in an interview.

Masimo, Covidien Sales, and GE Healthcare have yet to settle. “We are pleased that Medtronic, which holds a dominant share in the pulse oximeter market, has agreed to prioritize patient safety ...

Recently, Masimo announced the FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available over the counter to consumers without a prescription, which has become the first ...

The global pulse oximeters market reached a value of US$ 2.14 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 3.25 Billion by 2027, exhibiting a CAGR of 7.1% during ...

Goodwin’s work is expected to continue because it’s secured private funding from one of the biggest pulse oximeter manufacturers, Masimo. His research team has recruited nearly 200 patients so ...